These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34018353)

  • 1. [Research and Application of Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis: A Review].
    Feng XR; Yao J; Wu Y; Cheng X; Zou PJ; Wang H; Yang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):373-379. PubMed ID: 34018353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem Cell and Idiopathic Pulmonary Fibrosis: Mechanisms and Treatment.
    Liu M; Ren D; Wu D; Zheng J; Tu W
    Curr Stem Cell Res Ther; 2015; 10(6):466-76. PubMed ID: 25986617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-based therapies for the treatment of idiopathic pulmonary fibrosis (IPF) disease.
    Ghadiri M; Young PM; Traini D
    Expert Opin Biol Ther; 2016; 16(3):375-87. PubMed ID: 26593230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial.
    Glassberg MK; Minkiewicz J; Toonkel RL; Simonet ES; Rubio GA; DiFede D; Shafazand S; Khan A; Pujol MV; LaRussa VF; Lancaster LH; Rosen GD; Fishman J; Mageto YN; Mendizabal A; Hare JM
    Chest; 2017 May; 151(5):971-981. PubMed ID: 27890713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.
    Atanasova E; Milosevic D; Bornschlegl S; Krucker KP; Jacob EK; Carmona Porquera EM; Anderson DK; Egan AM; Limper AH; Dietz AB
    Stem Cell Res Ther; 2022 Jan; 13(1):45. PubMed ID: 35101101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem Cell-Derived Extracellular Vesicles as Idiopathic Pulmonary Fibrosis Microenvironment Targeted Delivery.
    Sang L; Guo X; Fan H; Shi J; Hou S; Lv Q
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing.
    Toonkel RL; Hare JM; Matthay MA; Glassberg MK
    Am J Respir Crit Care Med; 2013 Jul; 188(2):133-40. PubMed ID: 23306542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Au nanoparticles for engineering and long-term CT imaging tracking of mesenchymal stem cells in idiopathic pulmonary fibrosis treatment.
    Bao H; Cheng S; Li X; Li Y; Yu C; Huang J; Zhang Z
    Biomaterials; 2022 Sep; 288():121731. PubMed ID: 35970616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of stem cell transplantation for cell replacement or cytoprotective effect of microvesicle released from mesenchymal stem cell.
    Choi M; Ban T; Rhim T
    Mol Cells; 2014 Feb; 37(2):133-9. PubMed ID: 24598998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis.
    Shi L; Han Q; Hong Y; Li W; Gong G; Cui J; Mao M; Liang X; Hu B; Li X; Luo Q; Zhang Y
    Stem Cell Res Ther; 2021 Feb; 12(1):147. PubMed ID: 33632305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Mesenchymal Stem Cells and Extracellular Vesicles in Idiopathic Pulmonary Fibrosis.
    Kletukhina S; Mutallapova G; Titova A; Gomzikova M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy.
    Gharaee-Kermani M; Gyetko MR; Hu B; Phan SH
    Pharm Res; 2007 May; 24(5):819-41. PubMed ID: 17333393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.
    Zhao Y; Yan Z; Liu Y; Zhang Y; Shi J; Li J; Ji F
    Stem Cell Res Ther; 2021 Aug; 12(1):470. PubMed ID: 34420515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CoQ10 enhances the efficacy of airway basal stem cell transplantation on bleomycin-induced idiopathic pulmonary fibrosis in mice.
    Liu H; Liu S; Jiang J; Zhang Y; Luo Y; Zhao J; Xu J; Xie Y; Liao W; Wang W; Nie Y; Li S; Deng W
    Respir Res; 2022 Feb; 23(1):39. PubMed ID: 35219329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis.
    Boesch M; Baty F; Brutsche MH; Tamm M; Roux J; Knudsen L; Gazdhar A; Geiser T; Khan P; Hostettler KE
    Respir Res; 2020 Jun; 21(1):165. PubMed ID: 32605572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Senescence of bone marrow-derived mesenchymal stem cells from patients with idiopathic pulmonary fibrosis.
    Cárdenes N; Álvarez D; Sellarés J; Peng Y; Corey C; Wecht S; Nouraie SM; Shanker S; Sembrat J; Bueno M; Shiva S; Mora AL; Rojas M
    Stem Cell Res Ther; 2018 Sep; 9(1):257. PubMed ID: 30257725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-based therapy for idiopathic pulmonary fibrosis.
    Lu Q; El-Hashash AHK
    Stem Cell Investig; 2019; 6():22. PubMed ID: 31559309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS-activatable nanocomposites for CT imaging tracking and antioxidative protection of mesenchymal stem cells in idiopathic pulmonary fibrosis therapy.
    Lv Y; Yu C; Li X; Bao H; Song S; Cao X; Lin H; Huang J; Zhang Z
    J Control Release; 2023 May; 357():249-263. PubMed ID: 37011837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Regenerative Power of Stem Cells: Treating Bleomycin-Induced Lung Fibrosis.
    Vats A; Chaturvedi P
    Stem Cells Cloning; 2023; 16():43-59. PubMed ID: 37719787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.